Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YM155 with Carboplatin and Paclitaxel in Solid Tumors and NSCLC
NCT01100931Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Feb 2010
- Primary completion
- Dec 2012
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sepantronium in non-small cell lung cancer (NSCLC), solid tumor, sponsored by National Cancer Institute. Started Feb 2010; status: completed.
02
Drugs
sepantronium
03
Conditions
non-small cell lung cancer (NSCLC)solid tumor
Beyond the preview
Go deeper on NCT01100931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01100931.